Showing results (71-80 of 164) with videos related to
Sort By:
Pageof 17
American Journal of Psychotherapy|July 1, 1986
Benefits and limitations of neuroleptics--and other forms of treatment--in schizophreniaS R Marder, P R MayProceedings of the National Academy of Sciences of the United States of America|December 1, 1993
An investigation of the interrelationships between linear and nonlinear polarizabilities and bond-length alternation in conjugated organic moleculesC B Gorman, S R MarderArchives of General Psychiatry|September 1, 1978
Test dose response in schizophrenia: chlorpromazine blood and saliva levelsP R May, T Van Putten, D J Jenden, et al.Psychopharmacology|November 11, 1998
Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of ratM Aravagiri, A Yuwiler, S R MarderBiopharmaceutics & Drug Disposition|June 28, 2000
Pharmacokinetics and tissue distribution of olanzapine in ratsM Aravagiri, Y Teper, S R MarderJournal of Abnormal Psychology|February 1, 1996
Display visual angle and attentional scanpaths on the span of apprehension task in schizophreniaE Granholm, R F Asarnow, S R MarderAmerican Journal of Public Health|June 1, 1992
Neuroleptic medication and prescription practices with sheltered-care residents: a 12-year perspectiveS P Segal, D Cohen, S R MarderJournal of Abnormal Psychology|February 1, 1991
Controlled information processing resources and the development of automatic detection responses in schizophreniaE Granholm, R F Asarnow, S R MarderThe Journal of Clinical Psychiatry|February 4, 1998
The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trialsS R Marder, J M Davis, G ChouinardThe American Journal of Psychiatry|October 1, 1980
Plasma and saliva levels of chlorpromazine and subjective responseT Van Putten, P R May, D J Jenden, et al.Pageof 17